Koninklijke Philips Free Cash Flow 2010-2024 | PHG
Koninklijke Philips annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Koninklijke Philips free cash flow for the quarter ending June 30, 2024 was -361.84, a year-over-year.
- Koninklijke Philips free cash flow for the twelve months ending June 30, 2024 was , a year-over-year.
- Koninklijke Philips annual free cash flow for 2023 was $1.816B, a 301.37% decline from 2022.
- Koninklijke Philips annual free cash flow for 2022 was $-0.902B, a 175.78% decline from 2021.
- Koninklijke Philips annual free cash flow for 2021 was $1.19B, a 47.38% decline from 2020.
| Koninklijke Philips Annual Free Cash Flow | |
|---|---|
| 2023 | 1,816.10 |
| 2022 | -901.88 |
| 2021 | 1,190.20 |
| 2020 | 2,261.75 |
| 2019 | 1,354.08 |
| 2018 | 1,306.19 |
| 2017 | 1,460.35 |
| 2016 | 1,306.90 |
| 2015 | 495.24 |
| 2014 | 812.20 |
| 2013 | 293.55 |
| 2012 | 2,060.33 |
| 2011 | 332.88 |
| 2010 | 2,167.29 |
| 2009 | 1,599.60 |
| Koninklijke Philips Quarterly Free Cash Flow | |
|---|---|
| 2024-06-30 | -361.84 |
| 2023-06-30 | 188.64 |
| 2023-03-31 | |
| 2022-06-30 | -903.51 |
| 2021-06-30 | 468.71 |
| 2020-06-30 | 344.64 |
| 2019-06-30 | 49.46 |
| 2018-06-30 | -38.16 |
| 2017-06-30 | 222.24 |
| 2016-12-31 | 1,306.90 |
| 2016-09-30 | 345.81 |
| 2016-06-30 | -9.04 |
| 2016-03-31 | -159.96 |
| 2015-12-31 | 495.24 |
| 2015-09-30 | -353.81 |
| 2015-06-30 | -462.39 |
| 2015-03-31 | -468.41 |
| 2014-12-31 | 812.20 |
| 2014-09-30 | 179.13 |
| 2014-06-30 | -78.19 |
| 2014-03-31 | -457.75 |
| 2013-12-31 | 293.55 |
| 2013-09-30 | -555.05 |
| 2013-06-30 | -711.72 |
| 2013-03-31 | -566.67 |
| 2012-12-31 | 2,060.33 |
| 2012-09-30 | 1,180.07 |
| 2012-06-30 | 578.29 |
| 2012-03-31 | 777.41 |
| 2011-12-31 | 332.88 |
| 2011-09-30 | -1,771.28 |
| 2011-06-30 | -1,542.49 |
| 2011-03-31 | -1,121.01 |
| 2010-12-31 | 2,167.29 |
| 2010-09-30 | 255.45 |
| 2010-06-30 | 284.57 |
| 2010-03-31 | -123.36 |
| 2009-12-31 | 1,599.60 |
| 2009-09-30 | 474.43 |
| 2009-06-30 | -829.45 |
| 2009-03-31 | -536.27 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $28.565B | $19.663B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.191B | 25.34 |
| Stryker (SYK) | United States | $136.398B | 31.87 |
| Boston Scientific (BSX) | United States | $118.797B | 36.17 |
| Medtronic (MDT) | Ireland | $113.103B | 16.83 |
| EssilorLuxottica (ESLOY) | France | $108.631B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.164B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.055B | 33.63 |
| ResMed (RMD) | United States | $35.728B | 31.46 |
| Terumo (TRUMY) | Japan | $27.682B | 39.09 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.353B | 14.70 |
| Baxter (BAX) | United States | $19.468B | 13.20 |
| Insulet (PODD) | United States | $14.384B | 60.52 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.531B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.301B | 30.81 |
| Demant (WILYY) | Denmark | $8.959B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.277B | 17.47 |
| BellRing Brands (BRBR) | United States | $7.157B | 30.26 |
| ICU Medical (ICUI) | United States | $4.006B | 38.23 |
| Perrigo (PRGO) | Ireland | $3.956B | 12.50 |
| Haemonetics (HAE) | United States | $3.858B | 19.08 |
| Neogen (NEOG) | United States | $3.708B | 38.91 |
| Prestige Consumer Healthcare (PBH) | United States | $3.667B | 18.27 |
| TG Therapeutics (TGTX) | United States | $3.640B | 38.54 |
| GN Store Nord (GNNDY) | Denmark | $3.441B | 20.73 |
| Envista Holdings (NVST) | United States | $3.164B | 16.88 |
| QuidelOrtho (QDEL) | United States | $2.930B | 18.47 |
| Agios Pharmaceuticals (AGIO) | United States | $2.609B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.323B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.999B | 33.54 |
| LeMaitre Vascular (LMAT) | United States | $1.991B | 53.07 |
| Warby Parker (WRBY) | United States | $1.506B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.489B | 10.75 |
| InMode (INMD) | Israel | $1.344B | 8.56 |
| AtriCure (ATRC) | United States | $1.257B | 0.00 |
| Owens & Minor (OMI) | United States | $1.226B | 9.46 |
| BioLife Solutions (BLFS) | United States | $1.196B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.153B | 0.00 |
| Evolus (EOLS) | United States | $0.999B | 0.00 |
| PetIQ (PETQ) | United States | $0.912B | 23.12 |
| Phibro Animal Health (PAHC) | United States | $0.870B | 18.04 |
| National Vision Holdings (EYE) | United States | $0.826B | 26.27 |
| Cresco Labs (CRLBF) | United States | $0.752B | 0.00 |
| Surmodics (SRDX) | United States | $0.566B | 120.21 |
| Valneva SE (VALN) | France | $0.511B | 0.00 |
| Quanterix (QTRX) | United States | $0.508B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.502B | 15.16 |
| ZimVie (ZIMV) | United States | $0.474B | 44.10 |
| Canopy Growth (CGC) | Canada | $0.441B | 0.00 |
| Cerus (CERS) | United States | $0.424B | 0.00 |
| Jin Medical (ZJYL) | China | $0.423B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.347B | 0.00 |
| Biote (BTMD) | United States | $0.339B | 15.62 |
| OraSure Technologies (OSUR) | United States | $0.338B | 8.71 |
| Aurora Cannabis (ACB) | Canada | $0.328B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.311B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.288B | 30.96 |
| Zynex (ZYXI) | United States | $0.253B | 44.33 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.69 |
| Omeros (OMER) | United States | $0.236B | 0.00 |
| MacroGenics (MGNX) | United States | $0.218B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.175B | 0.00 |
| High Tide (HITI) | Canada | $0.158B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.154B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.153B | 20.62 |
| Brainsway (BWAY) | Israel | $0.134B | 160.20 |
| Quipt Home Medical (QIPT) | United States | $0.120B | 0.00 |
| Veru (VERU) | United States | $0.119B | 0.00 |
| Fonar (FONR) | United States | $0.109B | 11.00 |
| InterCure (INCR) | Israel | $0.102B | 17.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 24.00 |
| Jushi Holdings (JUSHF) | United States | $0.094B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.091B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
| MariMed (MRMD) | United States | $0.068B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.068B | 4.44 |
| Modular Medical (MODD) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Exagen (XGN) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| Safety Shot (SHOT) | United States | $0.046B | 0.00 |
| Bright Green (BGXX) | United States | $0.045B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.043B | 0.00 |
| ImmuCell (ICCC) | United States | $0.030B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.11 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |